---
tags: 
title: "Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018"
authors: "Lorenzo Galluzzi, Ilio Vitale, Stuart A. Aaronson, John M. Abrams, Dieter Adam, Patrizia Agostinis, Emad S. Alnemri, Lucia Altucci, Ivano Amelio, David W. Andrews, Margherita Annicchiarico-Petruzzelli, Alexey V. Antonov, Eli Arama, Eric H. Baehrecke, Nickolai A. Barlev, Nicolas G. Bazan, Francesca Bernassola, Mathieu J. M. Bertrand, Katiuscia Bianchi, Mikhail V. Blagosklonny, Klas Blomgren, Christoph Borner, Patricia Boya, Catherine Brenner, Michelangelo Campanella, Eleonora Candi, Didac Carmona-Gutierrez, Francesco Cecconi, Francis K.-M. Chan, Navdeep S. Chandel, Emily H. Cheng, Jerry E. Chipuk, John A. Cidlowski, Aaron Ciechanover, Gerald M. Cohen, Marcus Conrad, Juan R. Cubillos-Ruiz, Peter E. Czabotar, Vincenzo D’Angiolella, Ted M. Dawson, Valina L. Dawson, Vincenzo De Laurenzi, Ruggero De Maria, Klaus-Michael Debatin, Ralph J. DeBerardinis, Mohanish Deshmukh, Nicola Di Daniele, Francesco Di Virgilio, Vishva M. Dixit, Scott J. Dixon, Colin S. Duckett, Brian D. Dynlacht, Wafik S. El-Deiry, John W. Elrod, Gian Maria Fimia, Simone Fulda, Ana J. García-Sáez, Abhishek D. Garg, Carmen Garrido, Evripidis Gavathiotis, Pierre Golstein, Eyal Gottlieb, Douglas R. Green, Lloyd A. Greene, Hinrich Gronemeyer, Atan Gross, Gyorgy Hajnoczky, J. Marie Hardwick, Isaac S. Harris, Michael O. Hengartner, Claudio Hetz, Hidenori Ichijo, Marja Jäättelä, Bertrand Joseph, Philipp J. Jost, Philippe P. Juin, William J. Kaiser, Michael Karin, Thomas Kaufmann, Oliver Kepp, Adi Kimchi, Richard N. Kitsis, Daniel J. Klionsky, Richard A. Knight, Sharad Kumar, Sam W. Lee, John J. Lemasters, Beth Levine, Andreas Linkermann, Stuart A. Lipton, Richard A. Lockshin, Carlos López-Otín, Scott W. Lowe, Tom Luedde, Enrico Lugli, Marion MacFarlane, Frank Madeo, Michal Malewicz, Walter Malorni, Gwenola Manic, Jean-Christophe Marine, Seamus J. Martin, Jean-Claude Martinou, Jan Paul Medema, Patrick Mehlen, Pascal Meier, Sonia Melino, Edward A. Miao, Jeffery D. Molkentin, Ute M. Moll, Cristina Muñoz-Pinedo, Shigekazu Nagata, Gabriel Nuñez, Andrew Oberst, Moshe Oren, Michael Overholtzer, Michele Pagano, Theocharis Panaretakis, Manolis Pasparakis, Josef M. Penninger, David M. Pereira, Shazib Pervaiz, Marcus E. Peter, Mauro Piacentini, Paolo Pinton, Jochen H.M. Prehn, Hamsa Puthalakath, Gabriel A. Rabinovich, Markus Rehm, Rosario Rizzuto, Cecilia M.P. Rodrigues, David C. Rubinsztein, Thomas Rudel, Kevin M. Ryan, Emre Sayan, Luca Scorrano, Feng Shao, Yufang Shi, John Silke, Hans-Uwe Simon, Antonella Sistigu, Brent R. Stockwell, Andreas Strasser, Gyorgy Szabadkai, Stephen W.G. Tait, Daolin Tang, Nektarios Tavernarakis, Andrew Thorburn, Yoshihide Tsujimoto, Boris Turk, Tom Vanden Berghe, Peter Vandenabeele, Matthew G. Vander Heiden, Andreas Villunger, Herbert W. Virgin, Karen H. Vousden, Domagoj Vucic, Erwin F. Wagner, Henning Walczak, David Wallach, Ying Wang, James A. Wells, Will Wood, Junying Yuan, Zahra Zakeri, Boris Zhivotovsky, Laurence Zitvogel, Gerry Melino, Guido Kroemer"
---

> [!Cite] 1.

Galluzzi, L. _et al._ Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. _Cell Death Differ_ **25**, 486–541 (2018).

>[!md]
> **FirstAuthor**:: Galluzzi, Lorenzo  
> **Author**:: Vitale, Ilio  
> **Author**:: Aaronson, Stuart A.  
> **Author**:: Abrams, John M.  
> **Author**:: Adam, Dieter  
> **Author**:: Agostinis, Patrizia  
> **Author**:: Alnemri, Emad S.  
> **Author**:: Altucci, Lucia  
> **Author**:: Amelio, Ivano  
> **Author**:: Andrews, David W.  
> **Author**:: Annicchiarico-Petruzzelli, Margherita  
> **Author**:: Antonov, Alexey V.  
> **Author**:: Arama, Eli  
> **Author**:: Baehrecke, Eric H.  
> **Author**:: Barlev, Nickolai A.  
> **Author**:: Bazan, Nicolas G.  
> **Author**:: Bernassola, Francesca  
> **Author**:: Bertrand, Mathieu J. M.  
> **Author**:: Bianchi, Katiuscia  
> **Author**:: Blagosklonny, Mikhail V.  
> **Author**:: Blomgren, Klas  
> **Author**:: Borner, Christoph  
> **Author**:: Boya, Patricia  
> **Author**:: Brenner, Catherine  
> **Author**:: Campanella, Michelangelo  
> **Author**:: Candi, Eleonora  
> **Author**:: Carmona-Gutierrez, Didac  
> **Author**:: Cecconi, Francesco  
> **Author**:: Chan, Francis K.-M.  
> **Author**:: Chandel, Navdeep S.  
> **Author**:: Cheng, Emily H.  
> **Author**:: Chipuk, Jerry E.  
> **Author**:: Cidlowski, John A.  
> **Author**:: Ciechanover, Aaron  
> **Author**:: Cohen, Gerald M.  
> **Author**:: Conrad, Marcus  
> **Author**:: Cubillos-Ruiz, Juan R.  
> **Author**:: Czabotar, Peter E.  
> **Author**:: D’Angiolella, Vincenzo  
> **Author**:: Dawson, Ted M.  
> **Author**:: Dawson, Valina L.  
> **Author**:: De Laurenzi, Vincenzo  
> **Author**:: De Maria, Ruggero  
> **Author**:: Debatin, Klaus-Michael  
> **Author**:: DeBerardinis, Ralph J.  
> **Author**:: Deshmukh, Mohanish  
> **Author**:: Di Daniele, Nicola  
> **Author**:: Di Virgilio, Francesco  
> **Author**:: Dixit, Vishva M.  
> **Author**:: Dixon, Scott J.  
> **Author**:: Duckett, Colin S.  
> **Author**:: Dynlacht, Brian D.  
> **Author**:: El-Deiry, Wafik S.  
> **Author**:: Elrod, John W.  
> **Author**:: Fimia, Gian Maria  
> **Author**:: Fulda, Simone  
> **Author**:: García-Sáez, Ana J.  
> **Author**:: Garg, Abhishek D.  
> **Author**:: Garrido, Carmen  
> **Author**:: Gavathiotis, Evripidis  
> **Author**:: Golstein, Pierre  
> **Author**:: Gottlieb, Eyal  
> **Author**:: Green, Douglas R.  
> **Author**:: Greene, Lloyd A.  
> **Author**:: Gronemeyer, Hinrich  
> **Author**:: Gross, Atan  
> **Author**:: Hajnoczky, Gyorgy  
> **Author**:: Hardwick, J. Marie  
> **Author**:: Harris, Isaac S.  
> **Author**:: Hengartner, Michael O.  
> **Author**:: Hetz, Claudio  
> **Author**:: Ichijo, Hidenori  
> **Author**:: Jäättelä, Marja  
> **Author**:: Joseph, Bertrand  
> **Author**:: Jost, Philipp J.  
> **Author**:: Juin, Philippe P.  
> **Author**:: Kaiser, William J.  
> **Author**:: Karin, Michael  
> **Author**:: Kaufmann, Thomas  
> **Author**:: Kepp, Oliver  
> **Author**:: Kimchi, Adi  
> **Author**:: Kitsis, Richard N.  
> **Author**:: Klionsky, Daniel J.  
> **Author**:: Knight, Richard A.  
> **Author**:: Kumar, Sharad  
> **Author**:: Lee, Sam W.  
> **Author**:: Lemasters, John J.  
> **Author**:: Levine, Beth  
> **Author**:: Linkermann, Andreas  
> **Author**:: Lipton, Stuart A.  
> **Author**:: Lockshin, Richard A.  
> **Author**:: López-Otín, Carlos  
> **Author**:: Lowe, Scott W.  
> **Author**:: Luedde, Tom  
> **Author**:: Lugli, Enrico  
> **Author**:: MacFarlane, Marion  
> **Author**:: Madeo, Frank  
> **Author**:: Malewicz, Michal  
> **Author**:: Malorni, Walter  
> **Author**:: Manic, Gwenola  
> **Author**:: Marine, Jean-Christophe  
> **Author**:: Martin, Seamus J.  
> **Author**:: Martinou, Jean-Claude  
> **Author**:: Medema, Jan Paul  
> **Author**:: Mehlen, Patrick  
> **Author**:: Meier, Pascal  
> **Author**:: Melino, Sonia  
> **Author**:: Miao, Edward A.  
> **Author**:: Molkentin, Jeffery D.  
> **Author**:: Moll, Ute M.  
> **Author**:: Muñoz-Pinedo, Cristina  
> **Author**:: Nagata, Shigekazu  
> **Author**:: Nuñez, Gabriel  
> **Author**:: Oberst, Andrew  
> **Author**:: Oren, Moshe  
> **Author**:: Overholtzer, Michael  
> **Author**:: Pagano, Michele  
> **Author**:: Panaretakis, Theocharis  
> **Author**:: Pasparakis, Manolis  
> **Author**:: Penninger, Josef M.  
> **Author**:: Pereira, David M.  
> **Author**:: Pervaiz, Shazib  
> **Author**:: Peter, Marcus E.  
> **Author**:: Piacentini, Mauro  
> **Author**:: Pinton, Paolo  
> **Author**:: Prehn, Jochen H.M.  
> **Author**:: Puthalakath, Hamsa  
> **Author**:: Rabinovich, Gabriel A.  
> **Author**:: Rehm, Markus  
> **Author**:: Rizzuto, Rosario  
> **Author**:: Rodrigues, Cecilia M.P.  
> **Author**:: Rubinsztein, David C.  
> **Author**:: Rudel, Thomas  
> **Author**:: Ryan, Kevin M.  
> **Author**:: Sayan, Emre  
> **Author**:: Scorrano, Luca  
> **Author**:: Shao, Feng  
> **Author**:: Shi, Yufang  
> **Author**:: Silke, John  
> **Author**:: Simon, Hans-Uwe  
> **Author**:: Sistigu, Antonella  
> **Author**:: Stockwell, Brent R.  
> **Author**:: Strasser, Andreas  
> **Author**:: Szabadkai, Gyorgy  
> **Author**:: Tait, Stephen W.G.  
> **Author**:: Tang, Daolin  
> **Author**:: Tavernarakis, Nektarios  
> **Author**:: Thorburn, Andrew  
> **Author**:: Tsujimoto, Yoshihide  
> **Author**:: Turk, Boris  
> **Author**:: Vanden Berghe, Tom  
> **Author**:: Vandenabeele, Peter  
> **Author**:: Vander Heiden, Matthew G.  
> **Author**:: Villunger, Andreas  
> **Author**:: Virgin, Herbert W.  
> **Author**:: Vousden, Karen H.  
> **Author**:: Vucic, Domagoj  
> **Author**:: Wagner, Erwin F.  
> **Author**:: Walczak, Henning  
> **Author**:: Wallach, David  
> **Author**:: Wang, Ying  
> **Author**:: Wells, James A.  
> **Author**:: Wood, Will  
> **Author**:: Yuan, Junying  
> **Author**:: Zakeri, Zahra  
> **Author**:: Zhivotovsky, Boris  
> **Author**:: Zitvogel, Laurence  
> **Author**:: Melino, Gerry  
> **Author**:: Kroemer, Guido  
~    
> **Title**:: Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018  
> **Year**:: 2018   
> **Citekey**:: Galluzzi-2018  
> **itemType**:: journalArticle  
> **Journal**:: *Cell Death & Differentiation*  
> **Volume**:: 25  
> **Issue**:: 3   
> **Pages**:: 486-541  
> **DOI**:: 10.1038/s41418-017-0012-4    

> [!LINK] 
>
>  [Galluzzi et al. - 2018 - Molecular mechanisms of cell death recommendations of the Nomenclature Committee on Cell Death 2018.pdf](file:///Users/romankoval/Library/Mobile%20Documents/com~apple~CloudDocs/Lib/ZotMove_files/Galluzzi%20et%20al.%20-%202018%20-%20Molecular%20mechanisms%20of%20cell%20death%20recommendations%20of%20the%20Nomenclature%20Committee%20on%20Cell%20Death%202018.pdf).

> [!Abstract]
>.
>
### Table of context

> [!quote]+ Highlight ([Page ](zotero://open-pdf/library/items/VCNLFB6P?page=486&annotation=KPY5MKQT))
> Introduction 

> [!quote]+ Highlight ([Page 2](zotero://open-pdf/library/items/VCNLFB6P?page=487&annotation=9USNA46Y))
> Intrinsic apoptosis 

> [!quote]+ Highlight ([Page 7](zotero://open-pdf/library/items/VCNLFB6P?page=492&annotation=ISSBRWML))
> Extrinsic apoptosis 

> [!quote]+ Highlight ([Page 10](zotero://open-pdf/library/items/VCNLFB6P?page=495&annotation=HV7Y4C5E))
> MPT-driven necrosis 

> [!quote]+ Highlight ([Page 11](zotero://open-pdf/library/items/VCNLFB6P?page=496&annotation=8RDTDQQE))
> Necroptosis 

> [!quote]+ Highlight ([Page 14](zotero://open-pdf/library/items/VCNLFB6P?page=499&annotation=T66Z4YHR))
> Ferroptosis 

> [!quote]+ Highlight ([Page 15](zotero://open-pdf/library/items/VCNLFB6P?page=500&annotation=FFLCWN8T))
> Pyroptosis 

> [!quote]+ Highlight ([Page 17](zotero://open-pdf/library/items/VCNLFB6P?page=502&annotation=DIGNW8HA))
> Parthanatos 

> [!quote]+ Highlight ([Page 18](zotero://open-pdf/library/items/VCNLFB6P?page=503&annotation=M3GRCYTC))
> Entotic cell death 

> [!quote]+ Highlight ([Page 19](zotero://open-pdf/library/items/VCNLFB6P?page=504&annotation=24JJITD3))
> NETotic cell death 

> [!quote]+ Highlight ([Page 20](zotero://open-pdf/library/items/VCNLFB6P?page=505&annotation=S6263CZD))
> Lysosome-dependent cell death 

> [!quote]+ Highlight ([Page 21](zotero://open-pdf/library/items/VCNLFB6P?page=506&annotation=RUDNJDP4))
> Autophagy-dependent cell death 

> [!quote]+ Highlight ([Page 22](zotero://open-pdf/library/items/VCNLFB6P?page=507&annotation=5T9GGYKJ))
> Immunogenic cell death 

> [!quote]+ Highlight ([Page 23](zotero://open-pdf/library/items/VCNLFB6P?page=508&annotation=HT54DBLM))
> Non-lethal processes 

> [!quote]+ Highlight ([Page 23](zotero://open-pdf/library/items/VCNLFB6P?page=508&annotation=HPWKIW3N))
> Cellular senescence 

> [!quote]+ Highlight ([Page 24](zotero://open-pdf/library/items/VCNLFB6P?page=509&annotation=Q6FMJ3MR))
> Mitotic catastrophe 

> [!quote]+ Highlight ([Page 25](zotero://open-pdf/library/items/VCNLFB6P?page=510&annotation=6FNMF9ZK))
> Terminal differentiation and others 

> [!quote]+ Highlight ([Page 25](zotero://open-pdf/library/items/VCNLFB6P?page=510&annotation=2BJ6LRS9))
> Concluding remarks 
### Ideas, thoughts, useful information

> [!quote]+ Note ([Page ](zotero://open-pdf/library/items/VCNLFB6P?page=486&annotation=8KQTH5N2))
  **Accidental cell death is instantaneous and catastrophic demise of cells exposed to severe insults.**

> [!quote]+ Note ([Page ](zotero://open-pdf/library/items/VCNLFB6P?page=486&annotation=RGBHUERY))
  **Regulated cell death is not unique to multicellular life forms, program that eliminate cell in response to intracellular or extracellular microenvironment changes, in some way prioritise general evolution than individual one.**

> [!quote]+ Note ([Page 2](zotero://open-pdf/library/items/VCNLFB6P?page=487&annotation=GL89KR56))
  **Morphologically cell death could be divided into three groups. Type 1 - exhibiting sytoplasmic shrinkage, pyknosis, karyorrhexis, and plasma membrane blebbing. Type 2 manifesting by excesive cytoplasmic vacuolization, increasing phaocytic uptake and lysosomal degradation. Type 3 displayin disposal of cell corpses in the absense of obvious phagocytic and lysosomal involvement.**

> [!quote]+ Highlight ([Page 7](zotero://open-pdf/library/items/VCNLFB6P?page=492&annotation=PGMWVR4M))
> NCCD proposes to define intrinsic apoptosis as a form of RCD initiated by perturbations of the intracellular or extracellular microenvironment, demarcated by MOMP and precipitated by executioner caspases, mainly CASP3 

> [!quote]+ Highlight ([Page 7](zotero://open-pdf/library/items/VCNLFB6P?page=492&annotation=7CKNX879))
> Extrinsic apoptosis is mostly driven by either of two types of plasma membrane receptors: (1) death receptors, whose activation depends on the binding of the cognate ligand(s), and (2) dependence receptors, whose activation occurs when the levels of their specific ligand drop below a specific threshold [267 269–271]. 

[[extrinsic apoptosis]]

> [!quote]+ Highlight ([Page 8](zotero://open-pdf/library/items/VCNLFB6P?page=493&annotation=S4JB48LR))
> FADD drives DISC assembly by promoting the death effector domain (DED)-dependent recruitment of CASP8 (or CASP10) and multiple isoforms of c-FLIP 

> [!quote]+ Highlight ([Page 8](zotero://open-pdf/library/items/VCNLFB6P?page=493&annotation=WNW3BPXQ))
> In contrast, TNFR1 signaling involves the association of TNFRSF1A associated via DD (TRADD), which acts as an adaptor for the assembly of complex I, generally consisting of TNF receptor associated factor 2 (TRAF2), TRAF5, c-IAP1, cIAP2, RIPK1, and the linear ubiquitin chain assembly complex (LUBAC), a supramolecular entity consisting of SHANK associated RH domain interactor (SHARPIN), RANBP2-type, and C3HC4-type zinc finger containing 1 (RBCK1; best known as HOIL-1), and ring finger protein 31 (RNF31; best known as HOIP) 

> [!quote]+ Highlight ([Page 8](zotero://open-pdf/library/items/VCNLFB6P?page=493&annotation=PCBA4VA7))
> c-FLIP isoforms and CASP8 seem to be recruited at the DISC to comparable levels [303], supporting the notion that elevated expression levels of c-FLIPL inhibit, rather than activate, extrinsic apoptosis possibly by disrupting CASP8 maturation [301, 

> [!quote]+ Highlight ([Page 8](zotero://open-pdf/library/items/VCNLFB6P?page=493&annotation=B7AJIAFB))
> Of note, CFLAR (the gene encoding c-FLIP) is under direct transcriptional control by NF-κB, which largely contributes to pro-survival TNFR1 signaling in specific circumstances (see below) [287, 296, 305]. 

> [!quote]+ Highlight ([Page 8](zotero://open-pdf/library/items/VCNLFB6P?page=493&annotation=T9DWG8TD))
> The enzymatic activity of CASP8 appears to be controlled by additional post-translational mechanisms, including (but not limited to): (1) phosphorylation at Y380, which inhibits the autoproteolytic activity of CASP8 upon FAS activation  [306], (2) phosphorylation at T273, which is catalyzed by polo like kinase 3 (PLK3) at the DISC and promotes CASP8 apoptotic functions [307], and (3) deubiquitination, which decreases CASP8 activity and interrupts extrinsic apoptosis [302]. 

> [!quote]+ Highlight ([Page 8](zotero://open-pdf/library/items/VCNLFB6P?page=493&annotation=57UGDEKP))
> A large body of evidence demonstrates that death receptor ligation does not necessarily culminate in RCD. In particular, TNFR1 activation can have diverse outcomes depending on multiple variables, such as the posttranslational modification status of RIPK1, which has a direct impact on the assembly of pro-survival vs. pro-death signaling complexes [323–325]. Thus, following tumor necrosis factor (TNF) stimulation, RIPK1 is recruited at complex I in a TRADD-independent manner, followed by RIPK1 polyubiquitination by c-IAP1, c-IAP2, and LUBAC [196, 324 326–329]. Polyubiquitinated RIPK1 promotes cell survival and inflammation by acting as a scaffold for the sequential recruitment of TGF-beta activated kinase 1/ MAP3K7-binding protein 2 (TAB2), TAB3, and mitogenactivated protein kinase kinase kinase 7 (MAP3K7; best known as TAK1), which can drive mitogen-activated 

> [!quote]+ Highlight ([Page 9](zotero://open-pdf/library/items/VCNLFB6P?page=494&annotation=2TYXT292))
> protein kinase (MAPK) signaling or IκB kinase (IKK)dependent NF-κB activation [283, 287 330–333]. Moreover, the phosphorylation of RIPK1 by TAK1, the IKK complex or mitogen-activated protein kinase-activated protein kinase 2 (MAPKAPK2; best known as MK2) appears to alter its ability to interact with FADD and CASP8, hence preventing the variants of TNF-induced RCD that depends on RIPK1 kinase activity and favoring RIPK1-independent TRADD-, FADD-, and CASP8-driven apoptosis [285 334–336]. Conversely, in the presence of socalled “SMAC mimetics” (which de facto operate as IAP inhibitors) [337], RIPK1 is deubiquitinated by CYLD lysine 63 deubiquitinase (CYLD), favoring its release from complex I and its association with FADD and CASP8 in the cytosol to form complex II, which drives extrinsic apoptosis [338]. Complex II formation also requires TRAF2 ubiquitination by HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 (HACE1) [339]. To add a further layer of complexity, the proteasomal degradation of TRAF2 appears to be prevented (at least in hepatocytes) by RIPK1, independently of its kinase activity [340, 341]. Of note, TNFR1 can also activate alternative RCD modalities, such as necroptosis (see below) 

> [!quote]+ Highlight ([Page 10](zotero://open-pdf/library/items/VCNLFB6P?page=495&annotation=KWBDZ9EZ))
> We propose to define extrinsic apoptosis as a type of RCD initiated by perturbations of the extracellular microenvironment that are detected by plasma membrane receptors, propagated by CASP8 (with the optional involvement of MOMP), and precipitated by executioner caspases, mainly CASP3 

> [!quote]+ Highlight ([Page 11](zotero://open-pdf/library/items/VCNLFB6P?page=496&annotation=EAVLIFM9))
> MPT-driven necrosis as a form of RCD triggered by perturbations of the intracellular microenvironment and relying on CYPD 

> [!quote]+ Note ([Page 11](zotero://open-pdf/library/items/VCNLFB6P?page=496&annotation=CRED4M5D))
  **Necroptosis initiated by FAS, TNFR1, pathogen recognition receptors such as TLR3, TLR4, and Z-DNA binding protein 1.**

> [!quote]+ Note ([Page 11](zotero://open-pdf/library/items/VCNLFB6P?page=496&annotation=MPK35BEB))
  **RIPK3 and MLKL are esential molecular components of necroptosis. RIPK3 activation by RIPK1 or other kinase promote MLKL phosphorylation, resulting in the formation of oligomer that translocate to the plasma membrane, where they bin specific phosphtidylinositol phosphate species.**

> [!quote]+ Highlight ([Page 11](zotero://open-pdf/library/items/VCNLFB6P?page=496&annotation=9I6JB6I5))
> Alternatively, RIPK3 can be activated following the RHIM-dependent interaction with (1) TRIF upon either TLR3 activation by double-stranded RNA (dsRNA) within endosomes, or TLR4 activation by lipopolysaccharide (LPS) or various DAMPs at the plasma membrane [428]; or (2) ZBP1, which operates as a sensor for cytosolic DNApromoting type I interferon (IFN) synthesis and NF-κB activation [439–441]. 

> [!quote]+ Highlight ([Page 12](zotero://open-pdf/library/items/VCNLFB6P?page=497&annotation=CMX5FAA5))
> MLKL oligomerization promotes a cascade of intracellular events involving (1) Ca2+ influx, which is presumably mediated by the MLKL target transient receptor potential cation channel subfamily M member 7 (TRPM7) [449]; and (2) PS exposure, which seems to be directly operated by MLKL 

> [!quote]+ Note ([Page 12](zotero://open-pdf/library/items/VCNLFB6P?page=497&annotation=E7NPGWBZ))
  **MLKL also promote Ca influx through TRPM7, and PS exposure.**

> [!quote]+ Note ([Page 12](zotero://open-pdf/library/items/VCNLFB6P?page=497&annotation=5V886HKT))
  **Pseudonecrosis has been describe by involving just MLKL or RIPK3**

> [!quote]+ Highlight ([Page 12](zotero://open-pdf/library/items/VCNLFB6P?page=497&annotation=9R2M43AI))
> Major negative regulators of the necrosome include: (1) STIP1 homology and U-box containing protein 1 (STUB1; also known as CHIP), which promotes RIPK1 and RIPK3 ubiquitination followed by lysosomal degradation [472, 473]; (2) A20, which inhibits necrosome assembly by deubiquitinating RIPK3 [473, 474]; (3) protein phosphatase, Mg2+/Mn2+ dependent 1B (PPM1B), which prevents MLKL recruitment to the necrosome by dephosphorylating RIPK3 [475]; and (4) aurora kinase A (AURKA), which mediates inhibitory function upon physical interaction with RIPK1 and RIPK3 [476]. 

> [!quote]+ Highlight ([Page 12](zotero://open-pdf/library/items/VCNLFB6P?page=497&annotation=IKUMFNAS))
> In addition, the assembly of the necrosome upon TNFR1 stimulation impinges on two conditions: (1) pharmacological or genetic CASP8 inactivation [478, 479], and (2) RIPK1 deubiquitination-dependent phosphorylation (at least in some settings), which can be favored by exogenously provided SMAC mimetics, ensuring the release of RIPK1 from complex I (see above) [334, 335, 480, 481]. 

> [!quote]+ Highlight ([Page 12](zotero://open-pdf/library/items/VCNLFB6P?page=497&annotation=E5VKQA6D))
> Necroptosis is also tonically inhibited by c-IAPs, owing to their ability to ubiquitinate RIPK1 [490–493]. 

> [!quote]+ Highlight ([Page 13](zotero://open-pdf/library/items/VCNLFB6P?page=498&annotation=IGE3ATE4))
> Collectively, these results suggest that (at least in some settings) RIPK1 can inhibit (rather than activate) RIPK3-dependent necroptosis and/or CASP8dependent extrinsic apoptosis [504]. At least in some settings, this reflects the major role of RIPK1 in NF-κB activation [505–507]. 

> [!quote]+ Highlight ([Page 13](zotero://open-pdf/library/items/VCNLFB6P?page=498&annotation=DK8EBTS3))
> Thus, in the absence of CASP8 activity, stimulation of TLR3 or TLR4 by their respective ligands promotes necroptosis upon the interaction between TRIF and RIPK3 and the consequent activation of MLKL [428]. 

> [!quote]+ Highlight ([Page 13](zotero://open-pdf/library/items/VCNLFB6P?page=498&annotation=NNQHX72G))
> ZBP1 acts at the initial steps of necroptosis by mediating the sequential activation of RIPK3 and MLKL. 

> [!quote]+ Highlight ([Page 13](zotero://open-pdf/library/items/VCNLFB6P?page=498&annotation=XG74F7S2))
> Importantly, multiple components of the molecular machinery for necroptosis—including ZBP1, RIPK3, MLKL, and TNFR1 (mainly via NF-κB)—impinge on the control of the so-called “inflammasome”, a supramolecular platform for the activation of CASP1 and consequent secretion of mature interleukin 1 beta (IL1B; best known as IL-1β) and IL18 [524–529]. Discussing in detail these links —which exemplify the complex interconnection between RCD signaling and inflammatory responses—goes beyond the scope of this review [4, 8 530–532]. 

> [!quote]+ Highlight ([Page 14](zotero://open-pdf/library/items/VCNLFB6P?page=499&annotation=JYYKTLCB))
> we propose to define necroptosis as a type of RCD triggered by perturbations of extracellular or intracellular homeostasis that critically depends on MLKL, RIPK3, and (at least in some settings) on the kinase activity of RIPK1 

> [!quote]+ Highlight ([Page 18](zotero://open-pdf/library/items/VCNLFB6P?page=503&annotation=L3B6WA8J))
> parthanatos as a form of RCD initiated by PARP1 hyperactivation and precipitated by the consequent bioenergetic catastrophe coupled to AIFdependent and MIF-dependent DNA degradation 
### Questions, things that I didn't understand

> [!quote]+ Highlight ([Page ](zotero://open-pdf/library/items/VCNLFB6P?page=486&annotation=QAPGRVCM))
> Intriguingly, regulated cell death (RCD) is not unique to multicellular life forms, a setting in which RCD has an obvious advantage for organismal homeostasis in both physiological and pathological settings [5–9], 